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Abstract
 
During Kaposi’s sarcoma (KS)–associated herpesvirus (KSHV) lytic infection, many virus-encoded
signaling molecules (e.g., viral G protein–coupled receptor [vGPCR]) are produced that can
induce host gene expression in transiently transfected cells, and roles for such induced host
genes have been posited in KS pathogenesis. However, we have recently found that host
gene expression is strongly inhibited by 10–12 h after lytic reactivation of KSHV, raising the
question of whether and to what extent de novo host gene expression induced by viral sig-
naling molecules can proceed during the lytic cycle. Here, we show by microarray analysis
that expression of most vGPCR target genes is drastically curtailed by this host shutoff. How-
ever, rare cellular genes can escape the host shutoff and are potently up-regulated during lytic
KSHV growth. Prominent among these is human interleukin-6, whose striking induction
may contribute to the overexpression of this cytokine in several disease states linked to
KSHV infection.
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Introduction
 
Kaposi’s sarcoma (KS)–associated herpesvirus (KSHV) is
the etiologic agent of Kaposi’s sarcoma (1) and is also asso-
ciated with two lymphoproliferative disorders: multicentric
Castleman’s disease (MCD) and primary effusion lymphoma
(PEL; reference 2). KS is an angioproliferative lesion whose
predominant cells, spindle cells, are of endothelial lineage
and are thought to be a major source of the angiogenic
and inflammatory factors that drive KS histogenesis (3).
Although most KS spindle cells are latently infected by
KSHV, KS tumors also harbor a small subpopulation of
lytically infected spindle cells (4) that may provide an im-
portant source of secreted, proangiogenic, and mitogenic
factors contributing to disease progression (5, 6). For ex-
ample, the KSHV lytic program encodes several transmem-
brane  signaling molecules, including a viral G protein–
coupled receptor (vGPCR; reference 7) whose expression
in transfected cells induces transcription of multiple cellular
genes including cytokines, signaling molecules, and tran-
scription factors (8). KSHV vGPCR has attracted particu-
lar attention in KS pathogenesis because its expression can
induce cell proliferation and endothelial tube formation in
vitro, and angioproliferative lesions in transgenic mice in
vivo (7, 9).
However, this simple picture is complicated by our recent
finding that during the KSHV lytic cycle, there is a pro-
found shutoff of host gene expression mediated by the viral
shutoff exonuclease (SOX) protein (encoded by ORF37),
which promotes degradation of cellular mRNAs (10). These
observations raise important questions about the ability of
lytic viral signaling molecules to stimulate production of
host-encoded pathogenetic factors in infected spindle cells.
Here, we demonstrate that the vast majority of cellular
genes induced by exogenous vGPCR expression are not
similarly up-regulated in lytically infected cells, despite abun-
dant  expression of the vGPCR. However, we have also
identified a small subset of host transcripts that escape shut-
off, and note that some of these, including IL-6, may play
important roles in KSHV-related diseases.
 
Materials and Methods
 
Virus Preparation. 
 
The construction of Ad-RTA has been
described previously (11). Ad-vGPCR was generated using the
Adeno-X expression system according to the manufacturer’s pro-
tocols (CLONTECH Laboratories, Inc.). KSHV stocks were
generated as described previously (11).
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Cells, Transfections, and Virus Infections. 
 
Telomerase-immor-
talized microvascular endothelial (TIME) cells (12) and TIME
cells stably expressing destabilized green fluorescent protein (TIME-
dsGFP) were maintained in EBM-2 bullet kits (Clonetics).
KSHV
 
 
 
 BCBL-1 cells, human foreskin fibroblasts (HFFs), and
293 cells were maintained as described previously (11). 293T cells
were transfected using Fugene 6 (Roche).
TIME cells were infected with KSHV in serum-free media
and lytically reactivated as described previously (11). Adenovirus
infection was performed as described previously (11) in serum-
free EGM media. All cells were incubated in serum-free media
for a minimum of 16 h before harvest.
 
Immunofluorescence Microscopy Assays. 
 
Immunofluorescence
assays were performed as described previously (19). vGPCR anti-
bodies were provided by G. Hayward (The Johns Hopkins Uni-
versity School of Medicine, Baltimore, MD).
 
mRNA Amplification, Microarray Hybridization, and Data Analy-
sis. 
 
The human cDNA array has been described previously (8)
and represents 
 
 
 
20,000 genes derived from PCR of an ex-
pressed sequence tag (EST) clone set using common primers as
well as 
 
 
 
200 additional cDNAs amplified using gene-specific
primers for KSHV sequences and select additional cellular genes.
To generate mRNA for microarray analysis, 5 
 
 
 
g of total RNA
from each sample was subjected to linear mRNA amplification
by in vitro transcription of cDNA as described previously (13).
To generate each probe, 2 
 
 
 
g of the amplified RNA was reverse
transcribed in the presence of 300 
 
 
 
M amino-allyl dUTP as de-
scribed previously (14) and coupled to either Cy3 or Cy5 (Am-
ersham Biosciences). Probes were hybridized to the microarrays
overnight at 65
 
 
 
C. Arrays were scanned using an Axon 4000B
scanner, and Cy3 and Cy5 signals were normalized such that all
good features (r
 
2
 
 
 
 
 
 0.75) equaled 1. Arrays were analyzed using
GenePix 3.0 and clustered using TreeView. Spots with obvious
defects were excluded from the analysis. Each experiment was
repeated three independent times, and genes up-regulated at
least twofold greater than the reference sample in two or more
of the experiments were considered significant. The fold up-reg-
ulation reported in Tables I and II represents the average fold
up-regulation of that gene from the set of experiments. The
complete array datasets can be viewed on the NCBI-GEO web-
site (www.ncbi.nlm.nih.gov/geo, accession no. GSE1406).
 
Northern Blots and Immunoblots. 
 
Total RNA or poly(A) RNA
isolated from TIME cells for array analysis was Northern blotted as
described previously (8). Probes were generated using the Redi-
prime II random prime labeling system (Amersham Biosciences).
For immunoblots, cell lysates were prepared in radioimmuno-
precipitation assay buffer and immunoblotted as described previ-
ously (15) using HIF-1 monoclonal antibodies (Novus Biologicals).
 
Results
 
Experimental Strategy. 
 
To determine if vGPCR-
induced genes can escape KSHV-induced host shutoff, we
used DNA microarray analysis to compare the profile of
cellular genes up-regulated during lytic KSHV infection
with those up-regulated upon expression of vGPCR alone.
To this end, we infected TIME cells with an adenovirus
construct expressing vGPCR (Ad-vGPCR), resulting in
high-level expression of vGPCR mRNA (Fig. 1 A) and
protein (Fig. 1 B). For examination of host gene expression
during viral infection, we infected TIME cells with KSHV
and induced lytic replication 2 h later by superinfection
with an adenovirus encoding the KSHV lytic switch pro-
tein RTA (Ad-RTA; reference 11). IFA staining for the
early lytic viral protein ORF59 confirms that this system
allows lytic replication in the majority of the cells in the
culture (Fig. 1 C, column 4). To affirm that this KSHV in-
fection extinguished host gene expression under our exper-
imental conditions, we used an assay for shutoff based on
extinction of host GFP expression. TIME-dsGFP cells ex-
press a destabilized GFP (dsGFP); inhibition of host gene
expression results in rapid loss of dsGFP staining (10). As
shown in Fig. 1 C (column 2), latently infected TIME-
dsGFP cells were uniformly GFP
 
 
 
, whereas beginning at
7 h after lytic reactivation, ORF59
 
 
 
 cells had become
dsGFP
 
 
 
 and by 18 h, dsGFP staining is virtually absent
(Fig. 1 C, column 4).
Each microarray experiment consisted of six samples as
follows: normal TIME cells (used as the reference), TIME
cells infected with Ad-RTA or Ad-vGPCR alone for
20 h, or TIME cells infected with KSHV and immediately
reactivated with Ad-RTA for 6, 12, or 20 h. Cy5-labeled
probes were generated from each sample and mixed with
an equivalent amount of a Cy3-labeled control reference
probe derived from normal TIME cells and hybridized to
the microarray. Only genes that were up-regulated greater
Figure 1. Expression of Ad-vGPCR and KSHV in TIME cells. (A) TIME
cells were either mock infected or infected with Ad-vGPCR; 24 h after
infection, total RNA was Northern blotted with a 32P-labeled vGPCR
DNA probe. (B) The same infected cells were examined by DAPI staining
(left) or IFA with antibodies to vGPCR (right). (C) TIME cells stably ex-
pressing dsGFP were either mock infected, latently infected with KSHV,
or infected with KSHV and lytically reactivated with Ad-RTA for 7 or
18 h. Each row represents the same field of cells showing either DAPI-
stained nuclei (top), ORF59  cells (middle), or the merged image of
ORF59 and dsGFP (bottom). 
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than twofold specifically in vGPCR-expressing and/or
KSHV-infected cells, but not in mock-infected RTA-
expressing cells, in at least two out of three experiments
were tabulated.
 
The Majority of Cellular Gene Up-Regulation by vGPCR
Is Blocked by KSHV-induced Host Shutoff. 
 
Infection of
TIME cells with Ad-vGPCR induced up-regulation of
several cellular genes (Table I), many of which overlap
with those reported to be up-regulated in the endothelial
cell line SLK upon transient transfection with a vGPCR
plasmid (8). Significantly, we found that the majority of the
vGPCR-induced genes were not up-regulated at any time
during lytic KSHV infection. With the exception of IL-6,
ADAMTS1, and nucleoside phosphorylase (Table I), all
vGPCR-induced transcripts were absent by the 20-h reac-
tivation time point, indicating that they failed to escape
KSHV-induced gene shutoff. These findings are not attrib-
utable to the failure to express vGPCR during the lytic cy-
cle, as vGPCR transcripts were weakly detectable by 6 h
after infection, and accumulated strongly thereafter (Fig. 2
A). As expected, we detected strong induction of the ma-
jority of viral genes during the course of the lytic cycle (un-
published data), indicating that in these experiments pro-
ductive KSHV replication occurred.
Northern blot analysis of the vGPCR targets GRO1,
VEGF-C, and DUSP-5 (Fig. 2, B–D) verified that their
mRNA expression profiles parallel the array intensity re-
sults. Given that vGPCR is transcribed as a delayed-early
gene in midcycle, there exists only a short temporal win-
dow for vGPCR-induced transcripts to accumulate before
being degraded by the shutoff machinery.
 
Selected Cellular Genes Escape KSHV-induced Host Gene
Shutoff. 
 
Although most host genes were not up-regulated
during viral infection, there existed a small subset of host
genes, including IL-6, ADAMTS1, nucleoside phosphory-
lase, IL-1 receptor type I, solute carrier family 2, and gen-
eral transcription factor IIB, whose transcripts accumulated
during SOX-imposed shutoff (Tables I and II). Interest-
ingly, although the array analysis indicated that HIF-1
 
 
 
mRNA expression is only increased through the 12-h time
point in lytically infected cells, immunoblot analysis of
HIF-1
 
 
 
 demonstrates that the protein continues to accu-
mulate throughout the viral lytic cycle (Fig. 3 A).
Of these genes, one whose induction is particularly
striking is IL-6. To confirm the up-regulation of IL-6
mRNA during lytic growth, RNA from mock or lytically
infected TIME cells was examined by Northern blotting
for IL-6 and hsp70, a gene we demonstrated previously to
Figure 2. (A) vGPCR expression is detectable by 6 h after
lytic reactivation. DNA arrays were performed on samples
from TIME cells infected with Ad-RTA alone (RTA), or
KSHV plus Ad-RTA for 6, 12, or 20 h. The colored bar
represents an image taken from a TreeView cluster analysis,
where increasing red intensity represents increasing vGPCR
mRNA expression. Each array spot represented by the col-
ored bar is shown on the right along with the median inten-
sity of that spot. (B–D) Correlation of microarray and
Northern blot data for three selected host mRNAs. DNA
arrays were performed on samples from TIME cells in-
fected with Ad-RTA alone (RTA), Ad-vGPCR alone
(vGPCR), or KSHV and Ad-RTA for 6, 12, or 20 h. (left) As
in A, increasing red intensity represents increasing mRNA
expression of either GRO1 (B), VEGF-C (C), or DUSP-5
(D). (right) Northern blots of 100 ng of the corresponding
poly(A) RNA from each indicated infection, as well as 100
ng of poly(A) RNA from TIME cells latently infected with
KSHV, hybridized with 32P-labeled GRO1 (B), VEGF-C
(C), or DUSP-5 (D) DNA. 
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be susceptible to KSHV-induced host shutoff (10). The
lytically infected cells showed complete shutoff of the
hsp70 message, but strong up-regulation of IL-6 (Fig. 3 B,
left). IL-6 protein levels are similarly induced upon lytic
KSHV infection of TIME, HFF, and 293 cells (Fig. 3 C).
Thus, induction of IL-6 appears to be a conserved re-
sponse to lytic KSHV infection across multiple lineages.
IL-6 mRNA accumulates to levels far greater than those
present preinfection, suggesting that its accumulation is
not simply due to evasion of SOX-induced degradation,
but also may be actively induced. vGPCR has been
shown to induce IL-6 transcription (8) and, indeed, infec-
tion of TIME cells with Ad-vGPCR leads to augmented
IL-6 expression, though this increase is modest relative to
its induction during the KSHV lytic cycle (Fig. 3, B and
C). RTA has also been shown to induce IL-6 in 293T and
R1T cells (16), though we observed virtually no RTA-
induced IL-6 in TIME cells (Fig. 3, B and C, and Table
I), perhaps suggesting that up-regulation of IL-6 by RTA
is cell type specific. In agreement with this notion, we did
observe somewhat elevated levels of IL-6 in RTA-express-
ing HFFs (Fig. 3 C). We suspect that additional viral
regulators may also be involved in IL-6 up-regulation in
KSHV-infected cells.
However, transcriptional induction alone is unlikely to
account for the strong accumulation of IL-6 mRNA dur-
ing infection because many other vGPCR-induced tran-
scripts fail to accumulate under these conditions (Table I).
 
Table I. 
 
Genes Up-Regulated in TIME Cells by vGPCR Alone or by vGPCR during Lytic KSHV Infection
 
Average fold up-regulation
 
a
 
KSHV 
 
 
 
 AdRTA
Name RTA vGPCR t 
 
 
 
 6t  
 
 
 
 12 t 
 
 
 
 20
GenBank
ID
 
b
 
GRO-1 1.4 26.0 1.8 1.6 2.1 W4690
MCF.2-derived transforming sequence 0.7 20.7 0.7 0.9 0.7 H05800
TNF-
 
 
 
–induced protein 3 0.7 19.7 0.8 1.2 0.7 AA476272
Microvascular endothelial differentiation gene 1.7 9.1 1.4 1.3 1.6 AA045793
Speroxide dismutase 2, mitochondrial 1.0 9.2 1.3 1.9 1.5 AA488084
VCAM-1 1.0 7.5 0.9 0.9 1.0 H07071
CD83 antigen 0.8 5.3 1.3 0.8 0.9 AA111969
TRAF1 1.0 4.6 1.0 1.0 1.3 R71725
Suppressin 0.9 3.9 1.0 1.1 0.7 AA425806
TNF-
 
 
 
–induced protein 2 1.2 3.2 1.3 0.9 1.0 AA457114
Apoptosis inhibitor 2 0.9 2.8 1.0 1.0 0.8 H48706
Apoptosis inhibitor 1 1.3 2.8 1.1 0.5 1.1 AA702174
VEGF-C 1.4 11.6 3.5 1.5 2.0 H07991
IKB-
 
 
 
1.0 5.0 2.1 1.3 0.8 W55872
Mannose-binding lectin (protein C) 2, soluble 0.9 4.6 2.0 1.3 1.6 T69359
Cyclin D1 0.9 3.9 3.3 2.3 1.4 AA487700
Cytochrome 
 
c
 
-1 1.2 2.6 2.7 2.7 1.7 AA865265
DUSP5 1.5 2.9 4.5 3.3 2.0 W65461
Plasminogen activator, tissue 1.0 2.8 3.5 3.3 1.3 AA453728
Metallothionein 1G 0.8 1.7 3.9 3.3 1.2 H53340
IL-6 1.2 3.3 4.4 4.5 4.7 N98591
ADAMTS1 1.0 3.9 5.4 5.8 14.3 R76553
Nucleoside phosphorylase 1.0 3.4 5.1 4.4 4.1 AA430382
 
a
 
Average ratio as described in Materials and Methods of genes up-regulated in TIME cells either infected with AdRTA alone (RTA), AdvGPCR
alone (vGPCR), or lytically infected with KSHV (KSHV 
 
 
 
 AdRTA) for either 6, 12, or 20 h.
 
b
 
GenBank/EMBL/DDBJ accession no. of microarray EST clone. 
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To explore the possibility that IL-6 mRNA may also es-
cape SOX-induced degradation, we cotransfected SOX
and IL-6 expression vectors into 293T cells and examined
the resulting levels of IL-6 mRNA. Although accumula-
tion of control RNAs (e.g., GFP, GM-CSF) was strongly
inhibited by SOX, no loss of IL-6 mRNA occurred in the
presence of SOX (Fig. 3 D). These data indicate that cis-
acting sequences or structures in rare cellular transcripts
such as IL-6 may rescue the mRNA from the SOX-depen-
dent degradative pathway.
 
Discussion
 
We demonstrated previously that lytic KSHV replication
promotes a widespread shutoff of cellular gene expression
that likely occurs via enhanced mRNA turnover (10). In
this report, we have further characterized the consequences
of this mRNA shutoff using microarray-based expression
profiling. Our findings reveal that very few human tran-
scripts accumulate during infection, including most of
those induced by vGPCR.
This result has significant implications for the role of the
vGPCR in KS development. Isolated expression of
vGPCR in mammalian cells activates a variety of signaling
pathways, including the PI3K, p38, and JNK kinase cas-
cades (7, 9, 17). These signaling events stimulate mitogenic
and antiapoptotic pathways, but the oncogenic role of
these cell-autonomous signals in KS has been disputed be-
cause lytically infected cells are destined to die (6). How-
ever, vGPCR signaling also leads to up-regulation of VEGF
(9), a powerful endothelial mitogen that can promote an-
giogenesis in a paracrine fashion. This activity could be of
great importance in KS pathogenesis, as it does not require
long-term survival of individual lytically infected cells, only
a continuous supply of them.
Given the powerful constitutive signaling activity of
vGPCR and its intrinsic proangiogenic character, one par-
adox has been why KS develops so infrequently after
KSHV infection. In Western societies, where 2–7% of the
population is KSHV infected, KS is largely limited to
those developing HIV infection or receiving iatrogenic
immunosuppression. The attenuation of VEGF and other
vGPCR-dependent gene induction events by KSHV-
induced shutoff leads us to propose that only infections
with extensive lytic replication, such as those that may oc-
cur during cellular immune dysfunction, can generate suf-
ficient VEGF to contribute meaningfully to KS progres-
sion. This inference accords well with clinical observations
that link KS progression to elevated levels of circulating
KSHV DNA (18).
Figure 3. HIF-1 and IL-6 are potently up-regulated during lytic KSHV infection of cells. (A) TIME cells were infected with either Ad-RTA for 48 h
or KSHV plus Ad-RTA for the indicated times and harvested, and equivalent amounts of each lysate were immunoblotted with HIF-1 antibodies. (B)
TIME cells were either mock infected or infected with the indicated viruses for 20 h, and total RNA was probed with either 32P-labeled human IL-6 or
hsp70 DNA. (left) Cells were heat shocked at 42.5 C for 2 h before harvest to demonstrate efficient shutoff of the hsp70 message. (C) TIME, HFF, and
293 cells were either mock infected, infected with Ad-RTA or Ad-vGPCR alone, or infected with KSHV and lytically reactivated with Ad-RTA or
TPA for 24 h. The cells were incubated in serum-free media for the last 12 h of the infection, and IL-6 levels in the supernatants were measured using the
BD Opti EIA human IL-6 ELISA kit. (D) 293T cells were transfected with either empty vector or a plasmid expressing GFP, GM-CSF, or IL-6 or
cotransfected with plasmids expressing SOX and either GFP, GM-CSF, or IL-6 at a 4:1 ratio. Total RNA was Northern blotted using the indicated
32P-labeled DNA probes. 
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Another way that vGPCR could influence angiogenesis
in spite of the global SOX-induced host shutoff would be if
it were to be expressed outside the context of lytic infec-
tion. Attempts to detect vGPCR mRNA during latency
have failed, though given the potency of vGPCR’s signal-
ing activity, it is possible that transcript levels too low to
detect might still be functionally significant. Alternatively,
vGPCR might be induced outside of the lytic program in a
manner analogous to the KSHV K2 gene, which can be se-
lectively expressed upon exposure to IFN-
 
 
 
 in the absence
of authentic lytic induction (19).
Notably, a small subset of host transcripts are spared from
shutoff during lytic infection, and these include transcripts
with potential roles in the pathogenesis of KSHV-related
diseases. IL-6 is one such transcript. Enhanced IL-6 expres-
sion is a feature common to several KSHV-associated neo-
plasms, including MCD and PEL. Many PEL-derived cell
lines, which display both latent and lytic infection, secrete
substantial quantities of IL-6, and some of these appear to
depend at least in part on IL-6 for survival or growth (20).
Furthermore, although much of the IL-6 action in KSHV-
related MCD is likely encoded by the vIL6 (K2) gene (21),
at least one paper reports high levels of circulating human
IL-6 (22), and in such cases the mechanism we describe
could be one source of this IL-6.
The up-regulation of IL-6 in infected cells also raises
important mechanistic questions. As noted earlier, the
large accumulation of IL-6 transcripts suggests a dual
mechanism involving both enhanced production and di-
minished degradation. Indeed, we observed that even in
the absence of KSHV infection, IL-6 mRNAs were selec-
tively refractory to SOX-mediated degradation, suggesting
the presence of one or more cis-acting sequence elements
or structures that facilitate their escape from shutoff. Inter-
estingly, it has been shown recently that HSV-1 vhs-medi-
ated targeting of some cellular mRNAs for degradation is
based on sequence specificity (23), perhaps indicating that
there may also exist sequence elements that protect select
 
Table II.
 
Cellular Genes That Escape KSHV-induced Host Shutoff
 
Average fold up-regulation
 
a
 
KSHV 
 
 
 
 AdRTA
Name RTA vGPCR t 
 
 
 
 6t  
 
 
 
 12 t 
 
 
 
 20
GenBank
ID
 
b
 
vGPCR inducible genes
 
Cyclin D1 0.9 3.9 3.3 2.3 1.4 AA487700
Cytochrome 
 
c
 
-1 1.2 2.6 2.7 2.7 1.7 AA865265
DUSP5 1.5 2.9 4.5 3.3 2.0 W65461
Plasminogen activator, tissue 1.0 2.8 3.5 3.3 1.3 AA453728
Metallothionein 1G 0.8 1.7 3.9 3.3 1.2 H53340
 
vGPCR noninducible genes
 
Metallothionein 1H 0.8 0.7 3.3 2.7 1.4 H77766
Snail1, zinc finger protein 1.3 0.7 3.8 3.2 1.1 AA464983
Hypoxia-inducible factor 1 
 
 
 
1.5 1.6 3.8 3.7 2.5 AA598526
 
vGPCR inducible genes
 
IL-6 1.2 3.3 4.4 4.5 4.7 N98591
ADAMTS1 1.0 3.9 5.4 5.8 14.3 R76553
Nucleoside phosphorylase 1.0 3.4 5.1 4.4 4.1 AA430382
 
vGPCR noninducible genes
 
KIAA0808 1.0 1.5 5.3 3.4 2.4 N66992
IL-1 receptor type 1 1.2 1.0 3.9 3.2 2.7 AA464525
Solute carrier family 2, member 3 1.1 1.1 3.6 3.3 2.5 T97889
General transcription factor IIB 1.0 1.1 3.5 3.1 2.9 H23978
 
a
 
Average ratio as described in Materials and Methods of genes up-regulated in TIME cells infected with AdRTA alone (RTA), AdvGPCR alone
(vGPCR), or lytically infected with KSHV (KSHV 
 
 
 
 AdRTA) for either 6, 12, or 20 h.
 
b
 
GenBank accession no. of microarray EST clone. 
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mRNAs from host shutoff in that virus as well. The defi-
nition of these elements and the factors that recognize
them may shed considerable light on the mechanism of
SOX-induced RNA turnover as well as how viral mRNAs
escape this shutoff.
It is interesting that three of the induced genes in Table
II are involved in cellular transcription. In particular,
HIF-1
 
 
 
 is a heterodimeric basic helix-loop-helix transcrip-
tion factor that becomes stabilized under hypoxic condi-
tions. Stabilized HIF-1
 
 
 
 dimerizes with HIF-1
 
 
 
 and tran-
scriptionally activates several genes responsive to low oxygen
whose products play critical roles in tumor progression in-
cluding angiogenesis, cell growth, and energy metabolism
(24). Although we did not observe the escape of many
HIF-1 target genes in infected cells, one HIF-1 target is
up-regulated; that is, the transcript for solute carrier family
2, member 3 (GLUT3). Interestingly, it has been reported
that hypoxia also induces KSHV lytic reactivation (25), an
event likely mediated by the presence of functional
hypoxia response elements within the RTA and ORF34
promoters. Thus, an additional function for HIF-1 in lytic
cells may be to enhance KSHV replication via the stimula-
tion of select viral promoters, the products of which are not
subject to shutoff.
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